A Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Conditions: Cutaneous Melanoma; Non-small Cell Lung Cancer; Colorectal Neoplasms; Pancreatic Neoplasms; Mesothelioma Intervention: Drug: SGN-BB228 Sponsor: Seagen Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Asbestosis | Cancer | Cancer & Oncology | Melanoma | Mesothelioma | Research | Skin Cancer | Study